11.30 Overcoming Translational Challenges of Cross Reactivity to Develop a Clinically Relevant BBB-Penetrant Antibody Platform
Time: 11:30 am
day: Day One Track 1 AM
Details:
- Discussing the translational barriers of developing biologic-based drugs to cross the blood-brain barrier
- Navigating differences in BBB receptor profiles between in vivo models to ensure cross-reactivity
- Increasing confidence of in vivo toxicity studies to ensure safe translation to humans
